Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) EBT Margin (2016 - 2025)

Historic EBT Margin for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 1688.82%.

  • AC Immune's EBT Margin fell 17104100.0% to 1688.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 1642.83%, marking a year-over-year decrease of 14952800.0%. This contributed to the annual value of 186.43% for FY2024, which is 1799100.0% up from last year.
  • AC Immune's EBT Margin amounted to 1688.82% in Q3 2025, which was down 17104100.0% from 1622.43% recorded in Q2 2025.
  • AC Immune's EBT Margin's 5-year high stood at 18051.55% during Q1 2023, with a 5-year trough of 836700.0% in Q1 2021.
  • Moreover, its 5-year median value for EBT Margin was 3312.95% (2024), whereas its average is 55454.4%.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by 2000000000bps in 2021, then skyrocketed by 2000000000bps in 2022.
  • AC Immune's EBT Margin (Quarter) stood at 12296.53% in 2021, then soared by 78bps to 2662.93% in 2022, then tumbled by -585bps to 18242.31% in 2023, then surged by 92bps to 1389.09% in 2024, then dropped by -22bps to 1688.82% in 2025.
  • Its last three reported values are 1688.82% in Q3 2025, 1622.43% for Q2 2025, and 1922.12% during Q1 2025.